Ephrine Plus Tablet Supplement recalled over manufacturing violations
- Recall date
- October 6, 2021
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- ULTRAtab Laboratories, Inc. recalls Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
- Recall number
- F-0721-2022
- FDA classification
- Class II
- Brand / firm
- ULTRAtab Laboratories, Inc.
- Sold / distributed
- Bulk product was distributed to 2 distributors (NY, FL) who may have repackaged the product and further distributed finished product.
Why it was recalled
cGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ephrine Plus Tablet (Caffeine 200 mg, Vitamin C 25 mg) Supplement, ULTRAtab Laboratories, Inc., Highland, NY
Get recall alerts
Free email alert whenever ULTRAtab Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ULTRAtab Laboratories, Inc.